126 related articles for article (PubMed ID: 38865203)
1. Multiomics analysis reveals serine catabolism as a potential therapeutic target for MELAS.
Liufu T; Zhao X; Yu M; Xie Z; Meng L; Lv H; Zhang W; Yuan Y; Xing G; Deng J; Wang Z
FASEB J; 2024 Jun; 38(12):e23742. PubMed ID: 38865203
[TBL] [Abstract][Full Text] [Related]
2. SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells.
Zhang Y; Liu Z; Wang X; Jian H; Xiao H; Wen T
Cancer Gene Ther; 2022 Oct; 29(10):1514-1527. PubMed ID: 35422087
[TBL] [Abstract][Full Text] [Related]
3. Data-independent acquisition-based quantitative proteomic analysis of m.3243A>G MELAS reveals novel potential pathogenesis and therapeutic targets.
Chang X; Yin Z; Zhang W; Shi J; Pu C; Shi Q; Wang J; Zhang J; Yan L; Yang W; Guo J
Medicine (Baltimore); 2022 Oct; 101(41):e30938. PubMed ID: 36254078
[TBL] [Abstract][Full Text] [Related]
4. One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.
Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Rodenburg RJ; de Laat P; Smeitink JAM; Janssen MCH; Louw R
Metabolomics; 2021 Jan; 17(1):10. PubMed ID: 33438095
[TBL] [Abstract][Full Text] [Related]
5. β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells.
Jeong MH; Kim JH; Seo KS; Kwak TH; Park WJ
Biochem Biophys Res Commun; 2014 Nov; 454(3):417-22. PubMed ID: 25451262
[TBL] [Abstract][Full Text] [Related]
6. A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS).
Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Suomalainen A; Hakonen AH; Carroll CJ; Rodenburg RJ; de Laat PB; Janssen MCH; Smeitink JAM; Louw R
Mitochondrion; 2019 Mar; 45():38-45. PubMed ID: 29471047
[TBL] [Abstract][Full Text] [Related]
7. Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation.
Tschampa HJ; Urbach H; Greschus S; Kunz WS; Kornblum C
J Neurol; 2013 Apr; 260(4):1071-80. PubMed ID: 23196335
[TBL] [Abstract][Full Text] [Related]
8. Impediments to Heart Transplantation in Adults With MELAS
Di Toro A; Urtis M; Narula N; Giuliani L; Grasso M; Pasotti M; Pellegrini C; Serio A; Pilotto A; Antoniazzi E; Rampino T; Magrassi L; Valentini A; Cavallini A; Scelsi L; Ghio S; Abelli M; Olivotto I; Porcu M; Gavazzi A; Kodama T; Arbustini E
J Am Coll Cardiol; 2022 Oct; 80(15):1431-1443. PubMed ID: 36202533
[TBL] [Abstract][Full Text] [Related]
9. Mutations in mitochondrially encoded complex I enzyme as the second common cause in a cohort of Chinese patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes.
Zhao D; Hong D; Zhang W; Yao S; Qi X; Lv H; Zheng R; Feng L; Huang Y; Yuan Y; Wang Z
J Hum Genet; 2011 Nov; 56(11):759-64. PubMed ID: 21850008
[TBL] [Abstract][Full Text] [Related]
10. RNA-seq profiling, and impaired autophagic process in skeletal muscle of MELAS.
Deng J; Lu Y; Xie Z; Liu J; Yuan Y; Wang Z
Biochem Biophys Res Commun; 2020 Feb; 523(1):91-97. PubMed ID: 31836143
[TBL] [Abstract][Full Text] [Related]
11. Metabolic interventions against complex I deficiency in MELAS syndrome.
Majamaa K; Rusanen H; Remes A; Hassinen IE
Mol Cell Biochem; 1997 Sep; 174(1-2):291-6. PubMed ID: 9309702
[TBL] [Abstract][Full Text] [Related]
12. New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the
Endres D; Süß P; Maier SJ; Friedel E; Nickel K; Ziegler C; Fiebich BL; Glocker FX; Stock F; Egger K; Lange T; Dacko M; Venhoff N; Erny D; Doostkam S; Komlosi K; Domschke K; Tebartz van Elst L
Front Immunol; 2019; 10():412. PubMed ID: 30949164
[No Abstract] [Full Text] [Related]
13. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
[TBL] [Abstract][Full Text] [Related]
14. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model.
Frey S; Geffroy G; Desquiret-Dumas V; Gueguen N; Bris C; Belal S; Amati-Bonneau P; Chevrollier A; Barth M; Henrion D; Lenaers G; Bonneau D; Reynier P; Procaccio V
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):284-291. PubMed ID: 27815040
[TBL] [Abstract][Full Text] [Related]
15. Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Chakrabarty S; Govindaraj P; Sankaran BP; Nagappa M; Kabekkodu SP; Jayaram P; Mallya S; Deepha S; Ponmalar JNJ; Arivinda HR; Meena AK; Jha RK; Sinha S; Gayathri N; Taly AB; Thangaraj K; Satyamoorthy K
J Neurol; 2021 Jun; 268(6):2192-2207. PubMed ID: 33484326
[TBL] [Abstract][Full Text] [Related]
16. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
El-Hattab AW; Adesina AM; Jones J; Scaglia F
Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
[TBL] [Abstract][Full Text] [Related]
17. Fulminant cerebral venous thrombosis associated with the m.3243A>G MELAS mutation: A new guise for an old disease.
Nikolaus M; Tietze A; Schweizer L; Kaindl AM; Stenzel W; Schuelke M; Knierim E
Brain Dev; 2019 Nov; 41(10):901-904. PubMed ID: 31345444
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic uniqueness in an individual with MELAS.
Vanniarajan A; Nayak D; Reddy AG; Singh L; Thangaraj K
Am J Med Genet B Neuropsychiatr Genet; 2006 Jul; 141B(5):440-4. PubMed ID: 16741938
[TBL] [Abstract][Full Text] [Related]
19. Acute myocardial infarction in a patient with MELAS syndrome: a possible link?
Cosma J; Russo A; Schino S; Belli M; Mango R; Chiricolo G; Martuscelli E; Mariano EG
Minerva Cardiol Angiol; 2023 Aug; 71(4):374-380. PubMed ID: 35767235
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging pattern and pathophysiology of cerebellar stroke-like lesions in MELAS with m.3243A>G mutation: a case report.
Oyama M; Iizuka T; Nakahara J; Izawa Y
BMC Neurol; 2020 May; 20(1):167. PubMed ID: 32357846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
